Search

Xuemei M Cao

from Scituate, MA
Age ~62

Xuemei Cao Phones & Addresses

  • 97 Stockbridge Rd, Scituate, MA 02066 (781) 378-1886
  • 95 Stockbridge Rd, Scituate, MA 02066
  • Brooklyn, NY
  • 6 Catbird Ln, East Lyme, CT 06333 (860) 467-7679 (860) 691-8079
  • Groton, CT
  • South Setauket, NY
  • Port Jefferson Station, NY
  • 6 Catbird Ln, East Lyme, CT 06333 (860) 919-0357

Work

Position: Production Occupations

Education

Degree: Bachelor's degree or higher

Resumes

Resumes

Xuemei Cao Photo 1

Lead Designer

View page
Location:
Brooklyn, NY
Industry:
Entertainment
Work:
Universal Creative
Production Art Director

The Shakespeare Theatre of New Jersey Aug 2016 - Dec 2016
Scenic Charge

Adirondack Studios Aug 2016 - Dec 2016
Lead Designer

University of South Carolina May 2011 - May 2014
Teaching Assistant In Scenic Design and Painting

Tianjin People's Art Theater Aug 2004 - Aug 2011
Residential Set Designer and Scenic Charge
Education:
University of South Carolina 2011 - 2014
Masters, Design
Central Academy of Drama 2000 - 2004
Bachelors, Painting, Design, Drama, Film
Skills:
Drawing
Fine Art
Creative Design
Set Design
Painting
Microsoft Office
Adobe Photoshop
Performing Arts
Photoshop Rendering
Theatrical Production
Art Direction
Concept Art
Design
Languages:
English
Mandarin
Xuemei Cao Photo 2

Xuemei Cao

View page
Xuemei Cao Photo 3

Xuemei Cao

View page

Business Records

Name / Title
Company / Classification
Phones & Addresses
Xuemei Cao
Manager
YC TECH. LC
97 Stockbridge Rd, Scituate, MA 02066

Publications

Us Patents

Attenuated Forms Of Bovine Viral Diarrhea Virus

View page
US Patent:
6410032, Jun 25, 2002
Filed:
Oct 31, 2000
Appl. No.:
09/702330
Inventors:
Xuemei Cao - East Lyme CT
Michael G. Sheppard - Stonington CT
Assignee:
Pfizer Inc - New York NY
International Classification:
A61K 39193
US Classification:
4242181, 424 931, 424 936, 4242041, 4242051, 4352351, 435236, 4353201, 536 231, 536 234
Abstract:
The present invention is directed to a method of producing attenuated forms of bovine viral diarrhea (BVD) virus by mutating the N protease gene. The invention includes the attenuated viruses made by the method, antibodies generated using these viruses, and vaccines that can be used for immunizing cattle.

Attenuated Forms Of Bovine Viral Diarrhea Virus

View page
US Patent:
6410299, Jun 25, 2002
Filed:
Aug 29, 2000
Appl. No.:
09/649796
Inventors:
Xuemei Cao - East Lyme CT
Michael G. Sheppard - Stonington CT
Assignee:
Pfizer Inc. - New York NY
Pfizer Products Inc. - Groton CT
International Classification:
C12N 704
US Classification:
435236, 4352351, 4353201, 435325, 435455, 435456, 424 931, 424 936, 4242041, 4242045, 4242181, 536 231
Abstract:
The present invention is directed to a method of producing attenuated forms of bovine viral diarrhea (BVD) virus by mutating the N protease gene. The invention includes the attenuated viruses made by this method, antibodies generated using these viruses, and vaccines that can be used for immunizing cattle.

Attenuated Forms Of Bovine Viral Diarrhea Virus

View page
US Patent:
6916477, Jul 12, 2005
Filed:
Apr 29, 2002
Appl. No.:
10/134288
Inventors:
Xuemei Cao - East Lyme CT, US
Michael G. Sheppard - Stonington CT, US
Assignee:
Pfizer Inc. - New York NY
International Classification:
A61K039/12
A01N063/00
US Classification:
4242181, 424 932, 4352351, 4353201, 435 911, 435440, 435455, 435325, 536 231
Abstract:
The present invention is directed to a method of producing attenuated forms of bovine viral diarrhea (BVD) virus by mutating the Nprotease gene. The invention includes the attenuated viruses made by this method, antibodies generated using these viruses, and vaccines that can be used for immunizing cattle.

Generation Of Type I/Type Ii Hybrid Form Of Bovine Viral Diarrhea Virus For Use As Vaccine

View page
US Patent:
6974575, Dec 13, 2005
Filed:
Aug 27, 2002
Appl. No.:
10/228406
Inventors:
Xuemei Cao - East Lyme CT, US
Gabriele M. Zybarth - West Kingston RI, US
Assignee:
Pfizer Inc. - New York NY
Pfizer Products Inc. - Groton CT
International Classification:
A61K039/00
US Classification:
4241921, 4242051, 435 691
Abstract:
The present invention provides genetically engineered type I/type II hybrid BVDV viruses. The hybrid viruses, as well as the hybrid viral genome, can be used in immunogenic compositions and vaccines for protecting cattle from BVDV infection.

Safe Mutant Viral Vaccines

View page
US Patent:
7754222, Jul 13, 2010
Filed:
Apr 4, 2008
Appl. No.:
12/098015
Inventors:
Jay Gregory Calvert - Otsego MI, US
Michael K O'Hara - Kalamazoo MI, US
Xuemei Cao - Scituate MA, US
Assignee:
Pharmacia & Upjohn Company, LLC - Kalamazoo MI
International Classification:
A61K 39/12
A61K 39/295
US Classification:
4242181
Abstract:
The present invention provides safe vaccines and methods of preparing such vaccines. The vaccines of the present invention contain at least two live mutant viruses of the same family or nucleic acid molecules encoding such viruses, wherein each of the two viruses or the encoding nucleic acids contains a mutation that confers a desirable phenotype and the mutations in the viruses reside in the same genomic site such that the mutant viruses cannot recombine with each other to eliminate the mutations.

Safe Mutant Viral Vaccines

View page
US Patent:
7361357, Apr 22, 2008
Filed:
Jul 16, 2004
Appl. No.:
10/893712
Inventors:
Jay Gregory Calvert - Otsego MI, US
Michael K. O'Hara - Kalamazoo MI, US
Xuemei Cao - Scituate MA, US
Assignee:
Pfizer Inc. - New York NY
Pfizer Products Inc. - Groton CT
International Classification:
A61K 39/12
US Classification:
4242181
Abstract:
The present invention provides safe vaccines and methods of preparing such vaccines. The vaccines of the present invention contain at least two live mutant viruses of the same family or nucleic acid molecules encoding such viruses, wherein each of the two viruses or the encoding nucleic adds contains a mutation that confers a desirable phenotype and the mutations in the viruses reside in the same genomic site such that the mutant viruses cannot recombine with each other to eliminate the mutations.

Attenuated Forms Of Bovine Viral Diarrhea Virus

View page
US Patent:
20040146854, Jul 29, 2004
Filed:
Nov 21, 2001
Appl. No.:
09/989933
Inventors:
Xuemei Cao - East Lyme CT, US
Gabriele Zybarth - West Kingston RI, US
Assignee:
Pfizer Inc.
International Classification:
C12Q001/70
C07H021/04
C12N007/01
C12N015/86
US Classification:
435/005000, 435/069300, 435/235100, 435/456000, 435/325000, 536/023720
Abstract:
The present invention relates to attenuated forms of bovine viral diarrhea (BVD) viruses. In particular, the present invention relates to attenuated BVD viruses made by mutating the Nprotease gene and inserting a bovine ubiquitin coding sequence. The attenuated viruses of the present invention can be used to raise antibodies against BVDV. Immunogenic compositions and vaccine compositions, as well as therapeutic and diagnosis methods, are also provided by the present invention.

Marked Bovine Viral Diarrhea Virus Vaccines

View page
US Patent:
20080305130, Dec 11, 2008
Filed:
Nov 24, 2006
Appl. No.:
11/995779
Inventors:
Chichi Huang - Berwyn PA, US
Michael G. Sheppard - Victoria, AU
Xuemei Cao - Scituate MA, US
Gabriele M. Zybarth - Westport MA, US
International Classification:
A61K 39/12
C12N 7/00
C12Q 1/70
US Classification:
4242181, 4352351, 435 5
Abstract:
The present invention is directed to a bovine viral diarrhea virus comprising at least one helicase domain amino acid mutation wherein the mutation in the NS3 domain results in a loss of recognition by a monoclonal antibody raised against wild-type NS3 but wherein viral RNA replication and the generation of infectious virus is retained. The present invention is useful, for example, to produce a marked bovine viral diarrhea virus vaccine or to differentiate between vaccinated and infected or unvaccinated animals.
Xuemei M Cao from Scituate, MA, age ~62 Get Report